Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Authors:
Open Access
- 1 December 2012
- journal article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 10 (4) , 289-302
Abstract
Much attention has been devoted to neurodegenerative diseases involving redox processes. This review comprises an update involving redox processes reported in the considerable literature in recent years. The mechanism involves reactive oxygen species and oxidative stress, usually in the brain. There are many examples including Parkinson’s, Huntington’s, Alzheimer’s, prions, Down’s syndrome, ataxia, multiple sclerosis, Creutzfeldt-Jacob disease, amyotrophic lateral sclerosis, schizophrenia, and Tardive Dyskinesia. Evidence indicates a protective role for antioxidants, which may have clinical implications. A multifaceted approach to mode of action appears reasonable.Keywords
This publication has 103 references indexed in Scilit:
- Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhageBrain, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Oxidative stress and neurodegeneration: where are we now?Journal of Neurochemistry, 2006
- Oxidative Stress and Hematologic and Biochemical Parameters in Individuals With Down SyndromeMayo Clinic Proceedings, 2005
- Reactive Oxygen Species-mediated β-Cleavage of the Prion Protein in the Cellular Response to Oxidative StressJournal of Biological Chemistry, 2005
- Effects of Add‐on Melatonin Administration on Antioxidant Enzymes in Children with Epilepsy Taking Carbamazepine Monotherapy: A Randomized, Double‐blind, Placebo‐controlled TrialEpilepsia, 2004
- Down's syndrome astrocytes have greater antioxidant capacity than euploid astrocytesEuropean Journal of Neuroscience, 2004
- Regulation by interferon β-1a of reactive oxygen metabolites production by lymphocytes and monocytes and serum sulfhydryls in relapsing multiple sclerosis patientsNeurochemistry International, 2003
- Rationale for clinical trials of selenium as an antioxidant for the treatment of the cardiomyopathy of Friedreich's ataxiaMedical Hypotheses, 2002
- Ets-2 Is Induced by Oxidative Stress and Sensitizes Cells to H2O2-Induced Apoptosis: Implications for Down's SyndromeBiochemical and Biophysical Research Communications, 2001